{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T06:39:13Z","timestamp":1717396753099},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T00:00:00Z","timestamp":1424908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0113963","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T13:48:40Z","timestamp":1424958520000},"page":"e0113963","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immunogenicity and Protective Efficacy of a Vero Cell Culture-Derived Whole-Virus H7N9 Vaccine in Mice and Guinea Pigs"],"prefix":"10.1371","volume":"10","author":[{"given":"Walter","family":"Wodal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Schwendinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helga","family":"Savidis-Dacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian A.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Hohenadl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Br\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Portsmouth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Karner-Pichl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalida","family":"Balta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopold","family":"Grillberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otfried","family":"Kistner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Noel","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Keith","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,2,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"R Gao","year":"2013","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0140-6736(13)60938-1","article-title":"Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses","volume":"381","author":"D Liu","year":"2013","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature12515","article-title":"The genesis and source of the H7N9 influenza viruses causing human infections in China","volume":"502","author":"TT Lam","year":"2013","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1305584","article-title":"Clinical findings in 111 cases of influenza A (H7N9) virus infection","volume":"368","author":"HN Gao","year":"2013","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1304617","article-title":"Epidemiology of human infections with Avian Influenza A (H7N9) Virus in China","volume":"370","author":"Q Li","year":"2014","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"f4752","DOI":"10.1136\/bmj.f4752","article-title":"Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation","volume":"347","author":"X Qi","year":"2013","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.1242917","article-title":"Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses","volume":"342","author":"Y Shi","year":"2013","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.cell.2013.05.034","article-title":"Glycan receptor binding of the influenza A virus H7N9 hemagglutinin","volume":"153","author":"K Tharakaraman","year":"2013","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature12379","article-title":"Biological features of novel avian influenza A (H7N9) virus","volume":"499","author":"J Zhou","year":"2013","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S2213-2600(13)70138-3","article-title":"Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract","volume":"1","author":"MC Chan","year":"2013","journal-title":"Lancet Respir Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/mBio.00601-13","article-title":"The Novel Human Influenza A(H7N9) Virus Is Naturally Adapted to Efficient Growth in Human Lung Tissue","volume":"4","author":"J Knepper","year":"2013","journal-title":"MBio"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ajpath.2013.06.011","article-title":"Novel avian-origin influenza A (H7N9) virus attaches to epithelium in both upper and lower respiratory tract of humans","volume":"183","author":"D van Riel","year":"2013","journal-title":"Am J Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature12392","article-title":"Characterization of H7N9 influenza A viruses isolated from humans","volume":"501","author":"T Watanabe","year":"2013","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1126\/science.1240532","article-title":"H7N9 influenza viruses are transmissible in ferrets by respiratory droplet","volume":"341","author":"Q Zhang","year":"2013","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.4161\/hv.24939","article-title":"Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design","volume":"9","author":"AS De Groot","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1016\/j.vaccine.2012.03.061","article-title":"Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine","volume":"30","author":"HJ Ehrlich","year":"2012","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e9349","DOI":"10.1371\/journal.pone.0009349","article-title":"A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models","volume":"5","author":"O Kistner","year":"2010","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1016\/j.vaccine.2012.07.039","article-title":"A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory","volume":"30","author":"A Loew-Baselli","year":"2012","journal-title":"Vaccine"},{"key":"ref19","unstructured":"Twenty-second pandemic pharmacovigilance update (2010) EMA\/527985\/2010. <object-id pub-id-type=\"pmid\">25506974<\/object-id>"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1016\/j.vaccine.2007.05.013","article-title":"Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses","volume":"25","author":"O Kistner","year":"2007","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/infdis\/jir711","article-title":"A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies","volume":"205","author":"R Fritz","year":"2012","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0166-3542(99)00008-X","article-title":"One-hit models for virus inactivation studies","volume":"41","author":"M Kundi","year":"1999","journal-title":"Antiviral Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jviromet.2008.06.016","article-title":"Increased sensitivity for detecting avian influenza-specific antibodies by a modified hemagglutination inhibition assay using horse erythrocytes","volume":"153","author":"N Jia","year":"2008","journal-title":"J Virol Methods"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jviromet.2005.10.001","article-title":"Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test","volume":"132","author":"A Meijer","year":"2006","journal-title":"J Virol Methods"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/j.vaccine.2013.07.043","article-title":"Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A\/Anhui\/1\/2013 (H7N9) protection and heterologous A\/chicken\/Jalisco\/CPA1\/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus","volume":"31","author":"GE Smith","year":"2013","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e4857","DOI":"10.1371\/journal.pone.0004857","article-title":"Host genetic background strongly influences the response to influenza A virus infections","volume":"4","author":"B Srivastava","year":"2009","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1128\/JVI.00514-09","article-title":"Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice","volume":"83","author":"ACM Boon","year":"2009","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1128\/JVI.00101-10","article-title":"Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu","volume":"84","author":"A Sol\u00f3rzano","year":"2010","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"12825","DOI":"10.1128\/JVI.05930-11","article-title":"The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses","volume":"85","author":"N Pica","year":"2011","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1743-422X-9-212","article-title":"Immunization with live virus vaccine protects highly susceptible DBA\/2J mice from lethal influenza A H1N1 infection","volume":"9","author":"L Dengler","year":"2012","journal-title":"Virol J"},{"key":"ref31","first-page":"63","article-title":"Haemagglutination-inhibiting antibody to influenza virus","volume":"115","author":"JC de Jong","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S0022172400022610","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"D Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e23791","DOI":"10.1371\/journal.pone.0023791","article-title":"H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model","volume":"6","author":"MK Howard","year":"2011","journal-title":"PLoS One"},{"key":"ref34","unstructured":"Pandemic Influenza Vaccine H5N1 Baxter AG (2012) EPAR summary for the public. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/001200\/WC500049617.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/001200\/WC500049617.pdf<\/ext-link>. Accessed 26 October 2014."},{"key":"ref35","unstructured":"Vepacel (2012) EPAR summary for the public. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/002089\/WC500124226.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/002089\/WC500124226.pdf<\/ext-link>. Accessed 26 October 2014."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"RB Couch","year":"2013","journal-title":"J Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1128\/JVI.02434-12","article-title":"Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine","volume":"87","author":"S Rockman","year":"2013","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1128\/JVI.02444-09","article-title":"Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA\/2 mouse influenza model","volume":"84","author":"ACM Boon","year":"2010","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e1000138","DOI":"10.1371\/journal.ppat.1000138","article-title":"Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling","volume":"4","author":"F Geeraedts","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1016\/j.vaccine.2008.09.057","article-title":"Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model","volume":"26","author":"N Hagenaars","year":"2008","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1750-2659.2008.00038.x","article-title":"Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs","volume":"2","author":"F Geeraedts","year":"2008","journal-title":"Influenza Other Respir Viruses"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ni1343","article-title":"Influenza and the challenge for immunology","volume":"7","author":"PC Doherty","year":"2006","journal-title":"Nat Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2796.2011.02367.x","article-title":"Hallmarks of CD4 T cell immunity against influenza","volume":"269","author":"KK McKinstry","year":"2011","journal-title":"J Intern Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine","volume":"369","author":"LF Fries","year":"2013","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"234ra55","DOI":"10.1126\/scitranslmed.3008761","article-title":"A cell culture-derived MF59-adjuvanted pandemic A\/H7N9 vaccine is immunogenic in adults","volume":"6","author":"SA Bart","year":"2014","journal-title":"Sci Transl Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1016\/j.vaccine.2014.04.060","article-title":"Potency of an inactivated influenza vaccine prepared from A\/duck\/Mongolia\/119\/2008 (H7N9) against the challenge with A\/Anhui\/1\/2013 (H7N9)","volume":"32","author":"D-C Chu","year":"2014","journal-title":"Vaccine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.vaccine.2014.06.043","article-title":"Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses","volume":"32","author":"C-Y Wu","year":"2014","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1016\/j.vaccine.2014.07.087","article-title":"Complete protection against lethal challenge of novel H7N9 virus with heterologous inactivated H7 vaccine in mice","volume":"32","author":"LH Tang","year":"2014","journal-title":"Vaccine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1016\/j.vaccine.2014.06.016","article-title":"A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets","volume":"32","author":"S-S Wong","year":"2014","journal-title":"Vaccine"},{"key":"ref50","unstructured":"Celvapan (2012) EPAR summary for the public Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/000982\/WC500022671.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/000982\/WC500022671.pdf<\/ext-link>. Accessed 26 October 2014."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1056\/NEJMoa073121","article-title":"A clinical trial of a whole-virus H5N1 vaccine derived from cell culture","volume":"358","author":"HJ Ehrlich","year":"2008","journal-title":"N Engl J Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1086\/605608","article-title":"A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses","volume":"200","author":"HJ Ehrlich","year":"2009","journal-title":"J Infect Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1016\/j.vaccine.2012.07.077","article-title":"Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming","volume":"30","author":"MV van der Velden","year":"2012","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/infdis\/jit498","article-title":"Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population","volume":"209","author":"MV van der Velden","year":"2014","journal-title":"J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0113963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:08:52Z","timestamp":1540332532000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0113963"}},"subtitle":[],"editor":[{"given":"Stephen Mark","family":"Tompkins","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,2,26]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0113963","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,26]]}}}